Learn about the various educational opportunities available at this year’s virtual event.

NEW – Career development center

This year 24 Hours of Stem Cells is introducing a career development track that will allow you to access:

  • Free career advice from prominent researchers in the field
  • Career development resources such as resume building and career planning
  • Educational opportunities such as virtual training and handbooks

Take advantage of these new career development opportunities by visiting the Career Development Center.

Event certification
Participate in the following activities within the virtual environment to earn an event certificate of completion and free T-shirt*.  Event certification is only available until February 9, 2018.

  • View two presentations of your choice
  • Submit a question to one of our experts via a scheduled chat, a presentation, or a booth
  • Visit a booth in the Exhibit Hall
  • Visit a virtual training lab
  • Complete a short survey

Virtual training
Test your knowledge and sharpen your stem cell skills in one of our virtual training labs. Topics include pluripotent stem cell culture, basic cell culture, transfection and protein expression.


*No purchase necessary. This promotion is available only to qualifying attendees of 24 Hours of Stem Cells who earned an event certification. Qualifying attendees will receive a T-shirt. Qualifying attendees in China will receive a LED table lamp. Free T-shirt or lamp is available to eligible participants who submit a request no later than February 9, 2018 or until gift supplies are depleted, whichever comes first. The estimated value of the T-shirt is $12.00 USD, and the estimated value of the lamp is $15.00 USD. One free gift per person. Life Technologies will fulfill T-shirt size requests whenever possible, but reserves the right to substitute sizes if necessary. Healthcare professionals may not participate in this promotion. Government Officials may not participate in this promotion. The term Government Official includes anyone who acts in an official capacity for or on behalf of a government entity, department, or agency. By registering, you warrant that you are not prohibited by employment, contract, or law from accepting a gift from Life Technologies. Offer void where prohibited, licensed, or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Other restrictions may apply.

NOV 8 - 9 2017 Opens: 3:00 PM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
5th annual 24 Hours of Stem Cells™ virtual event
7 23 4759

Register for free to attend the 5th annual Gibco™ 24 Hours of Stem Cells™ virtual event, a major stem cell research event taking place around the world on November 9, 2017*.

During 24 Hours of Stem Cells, you can:

  • Access leading scientific presentations from prominent researchers and thought leaders around the world
  • Sharpen your stem cell skills and expertise with virtual training and certifications
  • Expand your research network and enrich your perspective on a global context

Experience all of this virtually, from the comfort of anywhere. Register today.


What attendees liked about last year's event Explore the virtual event




*Event hours: Log in any time after 8:00AM November 9th regardless of your time zone.

If you have additional questions, please contact Chelsie Fritz at

  • Senior Global Cell Culture Specialist, Thermo Fisher Scientific
  • Assistant Research Fellow, Institute of Molecular Biology
  • Head of the Stem Cell Unit, University Medical Center Göttingen
  • Senior Manager, R&D Cell Biology Life Sciences Solutions, Thermo Fisher Scientific
  • Postdoctoral researcher, Hubrecht Institute
  • Research Associate, Center of Regenerative Medicine (CMRB)
  • Graduate Student, University of North Carolina at Charlotte
  • Assistant Professor, The Department of Molecular Genetics, Weizmann Institute of Science
  • Senior Process Development Scientist, Cell and Gene Therapy Catapult
  • Development Engineer / Scientist II, BridGE@CCRM
  • Senior Staff Scientist, Thermo Fisher Scientific
  • Director of Scientific Alliances, MTI-GlobalStem
  • Assistant Professor, Indiana University School of Medicine
  • Associate Staff Scientist, Chinese University of Hong Kong
  • Associate Professor, CSIRO Australian Regenerative Medicine Institute, Monash University
  • Staff Scientist, Thermo Fisher Scientific
  • Assistant Professor, Univeristy of Minnesota
  • INSERM director, iSTEM and President, French Stem Cell Society
  • Communications Director, California Institute for Regenerative Medicine
  • Director, Max Planck Institute for Molecular Genetics
  • Chair of Anatomy and Embryology and Professor of Developmental Biology, Leiden University Medical Center
  • Scientist, Thermo Fisher Scientific
  • Independent Team Leader, Max Delbrueck Center for Molecular Medicine (MDC)
  • Head of Research, D'Or Institute for Research and Education and Professor of Biomedical Sciences, Federal University of Rio de Janeiro
  • Research Associate, CMR[B]
  • Chief Scientific Officer (CSO), Braingineering Technologies SARL
  • Director, Therapeutics, Organovo
  • Special Sales Account Manager, Mary Ann Liebert, Inc.
  • CEO and co-founder, EpiBone
  • Independent Fellow, IMCB, A*STAR and Adjunct Assistant Professor, SBS and LKCMedicine, NTU and Adjunct Assistant Professor, NUS Medicine, NUS
  • Cell Models Field Application Scientist (FAS), Cell Biology group, Thermo Fisher Scientific

Show Resources
Click below each speaker's photo to watch their Webcast

  • Mary Kay Bates
    Senior Global Cell Culture Specialist, Thermo Fisher Scientific
      Mary Kay Bates is a Senior Global Cell Culture Specialist with Thermo Fisher Scientific, where she provides cell culture expertise to colleagues and customers. Her knowledge is based on twenty years of experience in academic and industrial cell and molecular biology labs, focusing on cancer and gene therapy, authoring several publications. Mary Kay holds an M.S. in microbiology from the University of Wisconsin-Madison, and has presented seminars at institutes around the world.
    • Jun-An Chen
      Assistant Research Fellow, Institute of Molecular Biology
        The focus of research in my laboratory is to elucidate how neurons establish individual identity in the developing nervous system and why only specific neuron subtypes are vulnerable in the neurodegenerative diseases. We tackle these questions via studying non-coding RNAs and their roles during motor neuron generation and degeneration. My lab employs motor neurons generated from mouse and human embryonic (ES) and induced pluripotent (iPS) stem cells, as well as mouse animal models to investigate motor neuron development and disease. We have developed and generated a series of stem cells and animal models to study functions of microRNA and lncRNA by "gain-of-function" and "loss-od-function" approaches. Besides elucidating the basic molecular mechanisms underlying specification of neuronal diversity during CNS development, I apply the stem cell system to study motor neuron diseases. In particular, I am engaged in the establishment and study of patient specific iPS cell based models of Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS). iPS cell derived motor neurons are used in my lab to perform deep sequencing from healthy and ALS motor neurons and to functionally characterize non-coding RNA pathology in motor neuron. I am also a core member of Neuroscience Program and RNA program in Academia Sinica, which provides strong and solid consortium to give advices and exchange the ideas for our projects. In summary, I have multidisciplinary approaches, from in vitro stem cells to in vivo mouse models, to study motor neuron development and degeneration.
      • Lukas Cyganek
        Head of the Stem Cell Unit, University Medical Center Göttingen
          Lukas Cyganek is head of the Stem Cell Unit at the University Medical Center Göttingen ( The SCU offers support within the scope of generation, cultivation and characterization of patient-specific induced pluripotent stem cells (iPSCs), its genome editing as well as its in vitro differentiation into patient-specific cardiomyocytes. The SCU further offers their expertise in the analysis of iPSC-derived cardiomyocytes and engineered heart muscles on molecular and functional level for detailed phenotyping. Apart from the laboratory services, the SCU acts as biobank for patient-specific iPSCs and iPSC derivatives ( During his PhD at the European Neuroscience Institute Göttingen, Lukas Cyganek focused on the neurogenesis of the somatosensory system. In 2013, he joined the stem cell lab of Prof. Kaomei Guan in the cardiology at the University Medical Center Göttingen as a postdoctoral researcher, before he became head of the SCU in 2015. His recent research focusses on the generation of patient-specific as well as engineered iPSCs of and their applications in disease modelling of cardiovascular diseases, drug screening and tissue engineering.
        • Matthew Dallas
          Senior Manager, R&D Cell Biology Life Sciences Solutions, Thermo Fisher Scientific
            Matt is currently a Senior Manager in Cell Biology Research and Development at Thermo Fisher Scientific. He obtained his Ph.D. in Chemical and Biomolecular Engineering from the Whiting School of Engineering at Johns Hopkins University, training that included a fellowship within the Johns Hopkins Institute for NanoBioTechnology, a multi-disciplinary institution with efforts spanning basic biological science, clinical science, and public health. Matt joined the Gibco R&D team in 2012 and has led development programs spanning oncology, primary human tissue culture, and stem cell biology. His current team is responsible for new product and process development in basal cell culture media, fetal bovine and other animal sera, and recombinant proteins.
          • Helmuth Gehart
            Postdoctoral researcher, Hubrecht Institute
              Helmuth Gehart received his PhD from ETH Zurich (Zurich, Switzerland) in 2013. During his PhD training with Prof. Romeo Ricci, Helmuth studied the mechanisms behind Type II Diabetes and the complex cellular checkpoints that maintain balance to prevent disease. Thereafter, Helmuth aimed to combine his knowledge of signaling and metabolism with the fascinating field of stem cell biology. Thus, he joined the group of Prof. Hans Clevers at the Hubrecht Institute (Utrecht, Netherlands). There he investigates adult tissue stem cells of the liver and their use in clinical research and regenerative medicine.
            • Alessandro Giorgetti
              Research Associate, Center of Regenerative Medicine (CMRB)
                Dr. Giorgetti holds a Bachelor of Biology (1998) and PhD in Molecular Medicine from the University of Milan, Italy. She has a long-standing interest in hematopoietic stem cells, which started in her PhD thesis. She continued her studies in Dr. Rafii´s Lab at the Weill Cornell Medical College in New York. In 2008 she joined Center of Regenerative Medicine of Barcelona (CMRB). Her work contributed to the molecular understanding of nuclear reprogramming (Cell Stem Cell 2009; Nature Protocols 2010; Nature 2011, Stem Cells 2011, PNAS 2012, Nature Commun 2013). In 2012, she joined Inbiomed as Head of the Laboratory of Hematopoiesis and Blood Disorders. In 2013, she relocated to the Josep Carreras Leukaemia Research Institute where she contributed to develop new strategies for the in vitro generation of blood cells (Stem Cell Reports 2016; Exp Hematol 2017; Stem Cells 2017). Recently she relocated to the CMR[B] where she has just established herself as Team Leader.
              • Donna Goodenow
                Graduate Student, University of North Carolina at Charlotte
                  I was born, raised and am currently living in Charlotte, North Carolina. I received my Bachelors of Science in Biology from Queens University of Charlotte. Now I am a third year Biology PhD student at the University of North Carolina at Charlotte (UNCC). Before beginning graduate school, I worked at Carolinas Medical Center in the General Surgery Research Department studying hemorrhagic shock and reperfusion injury in a rat model. At UNCC, I study the effects of dietary bioflavonoids on mouse embryonic stem cells to determine if these flavonoids cause improper DNA repair leading to chromosomal translocations and cancer.
                • Jacob Hanna
                  Assistant Professor, The Department of Molecular Genetics, Weizmann Institute of Science
                    Dr. Hanna earned a B.Sc. in Medical Sciences (2001, summa cum laude), and a PhD/MD in clinical medicine (2007, summa cum laude), all from the Hebrew University of Jerusalem, Israel. For more than four years, he conducted postdoctoral research with Prof. Rudolf Jaenisch at the Whitehead Institute for Biomedical. In his recently established lab at the Weizmann Institute, Dr. Hanna combines diverse experimentation methods with computational biology to explore topics in embryonic stem cell biology, early embryonic development and the modeling of human diseases. Projects include deciphering the mechanisms by which IPS and germ cells are produced, characterizing unique naïve human pluripotent stem cells and various stages in early human development. In addition to helping elucidate the molecular basis of cell reprogramming, this research offers the promise of creating powerful research models for infertility, cancer, degenerative and autoimmune diseases such as type 1 diabetes. His numerous honors and fellowships include a Novartis Fellowship by the Helen Hay Whitney Foundation (2007), a Genzyme-Whitehead Fellowship for outstanding postdoctoral fellows (2009), the TR35 award by MIT review magazine for young innovators (2010), a European Research Council early career development award (2011), the Rappaport prize in biomedical research (2013), the Krill prize by the Wolf Foundation for outstanding research achievements (2013), featured among "40 under 40" innovative scientists by Cell press (2014) and recently became an EMBO member (2017).
                  • Jahid Hasan
                    Senior Process Development Scientist, Cell and Gene Therapy Catapult
                      Jahid is a Senior Process Development Scientist at the Cell and Gene Therapy Catapult where he has been working for the last 4 years on various upstream and downstream development projects including the Cell Plasticity platform programme. He holds a doctorate degree from the University of Leeds where he developed a method for decellularising porcine meniscus with bone blocks for use as a meniscal replacement therapy. Jahid completed the Biochemical Engineering undergraduate programme at University College London gaining an MEng degree during which he undertook a year of work at Lonza's Cell Culture Process Development team in Slough-UK. Here, he assessed medium formulation and stability on CHO cell culture.
                    • Calley Hirsch
                      Development Engineer / Scientist II, BridGE@CCRM
                        Calley Hirsch has been a Development Engineer / Scientist II at CCRM in Toronto for 8 months, where she specializes in upstream lentiviral production and gene delivery technologies. Prior to working at CCRM, Calley was a postdoctoral fellow at the Lunenfeld-Tanenbaum Research Institute in Toronto and MD Anderson Cancer Center in Houston working on pluripotent stem cells and somatic cell reprogramming. Calley received her PhD from the University of Saskatchewan.
                      • Navjot Kaur, PhD
                        Senior Staff Scientist, Thermo Fisher Scientific
                          Navjot Kaur is a Senior Staff Scientist at Thermo Fisher Scientific in the Cell Biology business based in Frederick, MD. She is part of a team focusing on research, development and commercialization of next generation tools and reagents for Neurobiology, stem cell culture and differentiation. She has served as an R&D lead for launch of over 8 new products in the market spanning Neurobiology, cryopreservation, and stem cell differentiation areas. Navjot has developed and utilized a range of research tools including media formulation optimization, verification & validation process, development of standardized QC assays, technology transfer, manufacturing protocols, experimental design and statistical analyses. Prior to starting at Thermo Fisher Scientific in 2007 as Staff Scientist, she joined University at Buffalo, NY as a Postdoctoral Fellow and published more than 20 research articles in peer-reviewed journals in the fields of Neurobiology, Cell Signaling, and Protein Biochemistry.
                        • James Kehler VMD, PhD
                          Director of Scientific Alliances, MTI-GlobalStem
                            James Kehler VMD, PhD is a comparative stem cell biologist who thrives on developing productive collaborations to translate scientific discoveries into transformative products. He trained at the University of Pennsylvania, where he received his VMD in 2002, and PhD in Cell and Molecular Biology in 2004. James has worked as a visiting researcher at the National Institutes of Health for over 10 years, where he and his collaborators at NEI, NCI, NINDS, NIDDK and NIAAA developed animal and stem cell-based models of human diseases. He has run workshops on reprogramming and gene-editing both at the NIH, as well as internationally. James has worked and consulted for several stem cell companies from product development and management to directing custom reprogramming and gene-editing services. In 2016, James joined MTI-GlobalStem, now part of Thermo Fisher Scientific, as Director of Scientific Alliances, to foster collaborative research projects with academic, biotech and pharmaceutical partners.
                          • Karl Koehler
                            Assistant Professor, Indiana University School of Medicine
                              Karl Koehler, PhD is an Assistant Professor of Otolaryngology-Head and Neck Surgery at Indiana University School of Medicine. He joined the faculty after completing his PhD degree in Medical Neuroscience in 2014 under the mentorship of Dr. Eri Hashino. Dr. Koehler began his career studying how embryonic and induced pluripotent stem cells could be used to produce neurons to treat hearing loss patients. His early work, published in Nature and Nature Protocols, detailed a novel culture system for growing mini inner ear organs, known as inner ear organoids, from mouse pluripotent stem cells. He then spearheaded an effort to decode the signaling mechanisms required to coax human pluripotent stem cells to become inner ear organoids. This work was recently published in Nature Biotechnology in June 2017. His research now focuses on using the organoid culture system as a platform to develop regenerative therapies for the inner ear and various craniofacial tissues. His work is funded by grants from the National Institute of Health and the Indiana Clinical and Translational Research Institute.
                            • Alan Lam
                              Associate Staff Scientist, Chinese University of Hong Kong
                                Dr Alan Lam graduated with a PhD (Biochemistry) from Chinese University of Hong Kong. He is currently the associate staff scientist in the Stem Cell Bioprocessing Group at the Bioprocessing Technology Institute, A*STAR, Singapore. His research interest focuses on developing scalable platforms using microcarriers for adult and pluripotent stem cell derivation, expansion and differentiation. A list of his publications can be found at
                              • Andrew Laslett
                                Associate Professor, CSIRO Australian Regenerative Medicine Institute, Monash University
                                  Dr. Andrew Laslett is a Research Team Leader with the CSIRO Manufacturing business unit, where he leads a human pluripotent stem cell biology research team; He also holds an Adjunct Associate Professor position with the Australian Regenerative Medicine Institute at Monash University and is an Honorary Senior Fellow with the School of BioSciences at Melbourne University. Since 2001, Andrew and his laboratory have focused on elucidating the complex biology of human embryonic stem cells (hESC), examined methods for the differentiation of hESC to renal progenitor cells and more recently begun comparing hESC to reprogrammed human cells termed induced pluripotent stem (iPS) cells. His laboratory is currently focused on exploiting the basic biology of these cell types to create novel cell lines and tools that enhance human pluripotent cell research translation within CSIRO, Australia and internationally. Prior to his current role with CSIRO, Andrew was a Senior Scientist and Group Leader of the Human Embryonic Stem Cell Technology Laboratory at the Australian Stem Cell Centre (ASCC) following Senior Research Fellow appointments in the Laboratory of Embryonic Stem Cell Biology and the Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University. He obtained his BSc (Hons) and PhD (1996) from Monash University prior to undertaking postdoctoral positions in both Hong Kong and Philadelphia, USA.
                                • Xiquan Liang
                                  Staff Scientist, Thermo Fisher Scientific
                                    Xiquan Liang graduated from City College of New York in 1999. He joined Thermo Fisher Scientific as a staff scientist in 2004. Since then he has led development of product development leadership in protein analysis, including High Molecular Weight MS standard, SILAC for protein identification and quantification, and Dynabeads-TiO2 for phosphopeptide enrichment. He is now engaged in product development in Synthetic Biology, including Bluegrass, GeneArt seamless DNA assembly tools, site-directed mutagenesis , and CRISPR-mediated mammalian cell engineering in the Life Sciences Solutions Group of Thermo Fisher Scientific in Carlsbad, CA. He is focused on developing tools for the entire Synthetic Biology workflow, specifically DNA cloning, Gene Synthesis and Assembly, and Molecular and Cell Engineering.
                                  • Alessandro Magli
                                    Assistant Professor, Univeristy of Minnesota
                                      Dr. Alessandro Magli has worked in the skeletal muscle field for over 10 years. After completing his college studies at the University of Modena and Reggio Emilia (Italy), Dr. Magli earned his doctoral degree in the same institution by studying the molecular regulation of skeletal muscle differentiation. He later moved to the University of Minnesota where he conducted his post-doctoral training in the laboratory of Rita Perlingeiro. During this time, he investigated the mechanisms of cell fate choice during development, with a special focus on the mesodermal lineage derivatives. In particular, these studies recently resulted in the identification of markers for the purification of myogenic progenitors from differentiating human pluripotent stem cells, a finding that may enable the application of these ES-derived myogenic cells in cell therapy of muscle diseases. Dr. Magli is author of multiple scientific papers and, among other achievements, he was recipient of the Minnesota Regenerative Medicine educational award in 2015
                                    • Cécile Martinat
                                      INSERM director, iSTEM and President, French Stem Cell Society
                                        Research projects developed by my group, that is implanted in the institute ISTEM, is to better understand physiological mechanisms implicated in the development of neuromuscular diseases and subsequently to develop new therapeutic strategies. We have three main domains of research: i). improve the protocols of differentiation to convert efficiently and reliably cell types of interest, i.e. motoneurons and muscle cells; ii). To improve our knowledge on the communication between motoneurons and muscle cells by developing new cellular systems iii). apply these different tools to neuromuscular diseases with the aim to decipher physiopathological mechanisms and to identify new pharmacological strategies. My group is mainly interested in two neuromusuclar diseases: myotonic dystrophy type 1 and spinal muscular atrophy. I recently took the head of the INSERM Unit located in ISTEM, institute dedicated to the use of human pluripotent stem cells to develop new therapeutic strategies for monogenic diseases. Two main of applications are developed in ISTEM: cell therapy and drug screening. More recently, I have been elected president of the French Society for Stem Cell Research (FSSCR, The main objective of this society, launched in January 2017, is to underpin and federate short and long-term efforts to ensure the place of France as a leader in the domain of stem cell research.
                                      • Kevin McCormack
                                        Communications Director, California Institute for Regenerative Medicine
                                          Kevin McCormack is the Communications Director at CIRM, the state's stem cell agency. He considers himself to be the official translator for the agency, working to turn complex language about equally complex science into everyday English that anyone can understand. Before joining the agency he spent more than 20 years working as a journalist, most of that in TV news in San Francisco.
                                        • Alexander Meissner
                                          Director, Max Planck Institute for Molecular Genetics
                                            Alexander Meissner studied Medical Biotechnology at the Technical University Berlin before starting his PhD studies with Rudolf Jaenisch at the Whitehead Institute/MIT in 2002. He completed his PhD in 2006 and spent the next year and a half working with Rudolf Jaenisch and Eric Lander before starting his own lab as an assistant professor in the Department of Stem Cell and Regenerative Biology at Harvard University and as an associate member of the Broad Institute in 2008. He was promoted to associate professor in 2012 and full professor with tenure in 2015. In 2016 he has been appointed as Director and Head of the Department of Genome regulation at the Max Planck Institute for Molecular Genetics in secondary employment and changed it to his principal employment in 2017.
                                          • Christine Mummery
                                            Chair of Anatomy and Embryology and Professor of Developmental Biology, Leiden University Medical Center
                                              Christine Mummery is Chair of Anatomy and Embryology and Professor of Developmental Biology at Leiden University Medical Center. Her research concerns cardiovascular development and disease models based on human pluripotent stem cells. Immediate interests are on developing biophysical techniques for characterization and functional analysis of cardiovascular cells from hPSC. In 2015 she became guest professor at the Technical University of Twente to develop organ-on-chip models. Dr. Mummery is a member of the Royal Netherlands Academy of Science, on the board of the Netherlands Medical Research Council and holds a European Research Council Advanced Grant to study cardiac development and disease in humans based on stem cell models. She wrote a lay-guide on stem cells "Stem Cell: Scientific Facts and Fiction" (Elsevier 2014) and is Editor-in-Chief of Stem Cell Reports, the journal of the International Society of Stem Cell Research. She is also on the editorial boards of Cell Stem Cell, Cardiovascular Research and Stem Cells.
                                            • Suman Pradhan
                                              Scientist, Thermo Fisher Scientific
                                                Dr. Pradhan joined Thermo Fisher scientific in 2016 and is currently working on next generation tools and technologies development with the goal of providing assays and methods for molecular characterization of stem cells and T cells utilizing methylation platform, array-based whole genome and transcriptomic profiling and TaqMan qPCR assays. He earned his Ph.D. in Molecular Biophysics from University of Calcutta, India, investigating the structural and functional consequences of binding of putative anti-cancer small molecules to chromatin in the context of transcription and disease. After graduating Dr. Pradhan moved to United States and did two postdocs -- a brief one at UC San Diego followed by a second postdoc at UC Los Angeles. He made a few seminal contributions in unraveling the mechanism of eukaryotic gene expression and silencing leveraging sophisticated biochemistry and extensive next generation sequencing approaches.
                                              • Alessandro Prigione
                                                Independent Team Leader, Max Delbrueck Center for Molecular Medicine (MDC)
                                                  Dr. Prigione is an Independent Team Leader at the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. His group was established in 2015 with the generous support of a junior investigator grant from the German Ministry of Education and Research (BMBF). Dr. Prigione received a M.D. from the University of Milan in 2002 and a Ph.D. from the San Raffaele Institute of Milan in 2008. During his Ph.D., Dr. Prigione worked on neurological diseases at the University of Milan-Bicocca and on mitochondrial disorders at the University of California in Davis, USA. As postdoctoral scientist at the Max Planck Institute for Molecular Genetics in Berlin, Dr. Prigione described for the first time the reconfiguration occurring to mitochondria during the reprogramming of human fibroblasts to iPSCs. The focus of the Prigione lab is now the application of iPSCs in modeling and treatment discovery of neurological diseases with mitochondrial impairment. His latest work was published in Cell Stem Cell in January 2017 and demonstrated the use of iPSC-derived neural cells for drug discovery of neurological disorders caused by mitochondrial DNA mutations.
                                                • Stevens Rehen
                                                  Head of Research, D'Or Institute for Research and Education and Professor of Biomedical Sciences, Federal University of Rio de Janeiro
                                                    Stevens Rehen received his Bachelor's degree, Master's degree, and Ph.D. at the Federal University of Rio de Janerio in Brazil. He later completed postdoctoral training at the University of California San Diego and The Scripps Research Institute. Over the past five years, Stevens has published over 76 peer-reviewed publications. Currently, Stevens is a Full Professor at the Federal University of Rio de Janerio. Additionally, he is the Head of Research at D'Or Institute for Research and Education (IDOR) and Regional Committee Member of the Pew Latin American Program in the Biomedical Sciences.
                                                  • Meritxell Rovira
                                                    Research Associate, CMR[B]
                                                      Meritxell Rovira holds a Bachelor in Biology (2001) from University of Barcelona and a PhD in Health and Life Science (2007) from University Pompeu Fabra. After her PhD she moved to USA in 2008 for her postdoctoral training at Johns Hopkins/School of Medicine to work in Steve D Leach and Mike Parsons laboratories, where she acquired expertise in adult pancreatic progenitors in mouse and zebrafish models. She came back to Barcelona in 2011 as a Marie Curie postdoctoral fellow at Jorge Ferrer laboratory (IDIBAPS) where she gained expertise in the field of epigenetics. After her postdoctoral training, she joined Núria López-Bigas laboratory at IRB as a research associate to stablish and supervise the experimental part of Núria's lab. She joined the CMR[B] in 2017 after being awarded with a Jovenes Investigadores fellowship from the Spanish Ministry. Meritxell's main research interest is the study of pancreatic progenitors in zebrafish, mouse and human. Embryonic pancreatic multipotent progenitors and adult pancreatic duct cells express common markers in all animal species studied thus far; suggesting that adult duct cells might be exploited to create a pool of β-cell progenitors. Thus my main research interest is to understand the transcriptional and epigenetic changes that occur between embryonic progenitors and adult cells, as well as the influence of the extrinsic signals from the surrounding mesenchymal cells. This knowledge will allow the identification of the molecular mechanisms that restrict the lineage potential of duct cells and could be used to create a model of β-cell regeneration for the treatment of Type 1 Diabetes.
                                                    • Jens Schwamborn
                                                      Chief Scientific Officer (CSO), Braingineering Technologies SARL
                                                        Since 2013 Jens C. Schwamborn, PhD, is head of the Developmental and Cellular Biology group at the Luxembourg Centre for Systems Biomedicine (LCSB) as well as Professor at the University of Luxembourg. Additionally, since 2016 Jens is Chief Scientific Officer of the biotech company Braingineering Technologies. In 2002 Jens obtained is diploma in Biochemistry from the University Witten/Herdecke in Germany and in 2005 his PhD in Biology from the University Muenster in Germany. He worked as a postdoctoral researcher at the Institute for Molecular Biotechnology in Vienna / Austria. The focus of his work over the last years was on Neurobiology, Stem Cell research and Parkinson's disease. In particular he is interested in using human induced pluripotent stem cells for the development of advanced approaches for in vitro disease modeling. Jens published more than 50 papers in peer reviewed journals, holds several patents and severs as reviewer for numerous journals and funding agencies.
                                                      • Benjamin Shephard
                                                        Director, Therapeutics, Organovo
                                                          Dr. Shepherd has more than 17 years of experience in Tissue Engineering and Regenerative Medicine research. Dr. Shepherd's research in vascular biology and microvascular tissue engineering has been focused on the ability to use creative approaches to generate microvascular networks to support the fabrication and surgical implantation of prevascularized neotissues. In addition to these research interests, he has successfully led early-stage research programs in liver biology, oncology and directed differentiation of stem cells within 3D and bioprinted tissues. Prior to joining Organovo, he was an Associate Research Scientist at the Yale School of Medicine, where he also conducted postdoctoral training. In addition to his appointment at Yale, he was a staff perfusionist at the University of Connecticut Health Center. Dr. Shepherd is a board certified clinical perfusionist (C.C.P.), received his Ph.D. in Physiological Sciences from the University of Arizona and a B.S. in Zoology from the University of Washington.
                                                        • Rebecca Shumbata
                                                          Special Sales Account Manager, Mary Ann Liebert, Inc.
                                                            Rebecca Appleby Shumbata received her degree from Connecticut College. Today, Rebecca is a scholarly publishing professional with over 15 years of experience. At Mary Ann Liebert publishers, Rebecca works with organizations to find topics and customize existing content, create new content, or extend planned live content into enduring educational materials that improve branding and generate leads. Before joining Mary Ann Liebert publishers, Rebecca worked with publishers and institutions to improve the dissemination of research at Kudos. Prior to that, Rebecca served as Senior Global Sales Manager for Hosting Platforms at Ingenta, previously Publishing Technology. Rebecca has 8 additional years of publishing experiencing working for publishers, Cell Press, published by Elsevier, and the New England Journal of Medicine, published by the Massachusetts Medical Society. Rebecca is also co-Chair of the Society for Scholarly Publishing Development Committee.
                                                          • Nina Tandon
                                                            CEO and co-founder, EpiBone
                                                              Nina Tandon is CEO and co-founder of EpiBone, the world's first company growing living human bones for skeletal reconstruction. She is the co-author of Super Cells: Building with Biology, a book that explores the new frontier of biotech. She is a TED Senior Fellow, Adjunct Professor of Electrical Engineering at the Cooper Union and a former Staff Associate Postdoctoral Researcher in the Laboratory for Stem Cells and Tissue Engineering, Columbia University. She has a Bachelor's in Electrical Engineering from the Cooper Union, a Master's in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, and an MBA from Columbia University. Her PhD research focused on studying electrical signaling in the context of tissue engineering, and has worked with cardiac, skin, bone, and neural tissue.
                                                            • Adrian Teo
                                                              Independent Fellow, IMCB, A*STAR and Adjunct Assistant Professor, SBS and LKCMedicine, NTU and Adjunct Assistant Professor, NUS Medicine, NUS
                                                                Adrian Teo is an Independent Fellow at IMCB and an Adjunct Assistant Professor at NTU and NUS. He obtained his B.Sc. (1st Class) from NUS and then worked on human pluripotent stem cells (hPSCs) with Ray Dunn, Ph.D., and Alan Colman, Ph.D., at ES Cell International Pte. Ltd. followed by IMB. In April 2008, he joined the laboratory of Ludovic Vallier, Ph.D., at the University of Cambridge to pursue his Ph.D., under the AGS(O) scholarship. Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He completed his Ph.D. in July 2010 and joined the laboratory of Ray Dunn, Ph.D., at IMB as a postdoctoral fellow before heading to the laboratory of Rohit Kulkarni, M.D. Ph.D., at Joslin Diabetes Center, Harvard Medical School. During his fellowship, he obtained HSCI seed grants and a JDRF fellowship to pursue his research interests in using hPSCs for in vitro disease modelling of diabetes. He currently runs the Stem Cells and Diabetes Laboratory with a major focus on differentiating human pluripotent stem cells (hPSCs) into pancreatic cells and cell types affected in diabetic complications to dissect the pathology of diabetes and its complications
                                                              • Ania Wronski
                                                                Cell Models Field Application Scientist (FAS), Cell Biology group, Thermo Fisher Scientific
                                                                  Ania Wronski, PhD, is the CellModels Field Application Scientist (FAS) for the Cell Biology group within Thermo Fisher Scientific. She is passionate about providing solutions for researchers applying Cell Models such as iPSCs to the world of drug discovery. As an FAS, Ania travels the country, supporting the cell biology sales force and helping life science researchers do amazing work. Ania received her PhD in molecular biology and biochemistry from the University of Queensland in Australia and completed a four year postdoctoral study in the lab of Charlotte Kuperwasser at Tufts University.
                                                                Live Chats

                                                                Scheduled Live Chats
                                                                Chat live with our stem cell experts on the topic of your interest – shown below.

                                                                LIVE CHAT: Mouse ESC/iPSC culture
                                                                6:00-7:00PM EST, November 8
                                                                Mark Kennedy and Soojung Shin
                                                                Our experts have tried different mouse ESC/iPSC culture systems, from feeder-dependent to feeder-free, from using serum-based media to 2i and a2i media. Additionally, they have tested a variety of our products for mouse ESC/iPSC applications. Find out what they would recommend for your experiment.

                                                                LIVE CHAT: Stem cell characterization and analysis
                                                                8:00-9:00PM EST, November 8
                                                                Don Paul Kovarcik and Uma Lakshmipathy
                                                                Characterizing and analyzing cells may be one of the most important steps in stem cell culture. Talk about your techniques and hear our expert opinions about different approaches to creating a complete characterization profile for your cells.

                                                                LIVE CHAT: Reprogramming
                                                                10:00-11:00PM EST, November 8
                                                                Uma Lakshmipathy and Chad MacArthur
                                                                Find out how our experts have evaluated different reprogramming methodologies and which ones they recommend for your cell type.

                                                                LIVE CHAT: Gene editing
                                                                12:00-1:00AM EST, November 8
                                                                Jason Carte and Erik Willems
                                                                Ask our experts about which gene editing tools work best for different cell lines and how to improve editing outcomes, or engage in a discussion about how gene editing in stem cells may change the future of modern medicine.

                                                                LIVE CHAT: Neural cell culture systems
                                                                8:00-9:00AM EST, November 9
                                                                Navjot Kaur and David Kuninger
                                                                Discuss the challenges associated with neural cell culture systems and how our latest product improvements and solutions can help.

                                                                LIVE CHAT: Transfection
                                                                11:00AM-12:00PM EST, November 9
                                                                James Kehler and Donna Trollinger
                                                                Ask our experts about the latest in our transfection portfolio including superior transfection efficiency in the most difficult stem cell assays.

                                                                LIVE CHAT: PSC culture
                                                                2:00-3:00PM EST, November 9
                                                                Rhonda Newman and Lauren Sangenario
                                                                Many different PSC culture media are available and range from feeder-dependent to feeder-free, and from many animal-derived components to more xeno-free formulations. Our experts have tried them all. Learn how they compare and recommend different media for your applications.

                                                                LIVE CHAT: Clinical research
                                                                4:00-5:00PM EST, November 9
                                                                Kasey Kime and Sandy Kuligowski
                                                                In need of practical advice on designing a cell-based clinical trial logistics strategy? Ask our knowledgeable scientists about the essential elements of material handling to control costs and ensure success.


                                                                General LabRoots Questions

                                                                For bugs, spam, technical support or questions please call +1-714-463-4673 or email  
                                                                Contact us

                                                                Virtual Events and Webinars

                                                                Supported Configurations

                                                                • Operating System Internet Explorer Firefox Chrome Safari
                                                                  Vista IE8+ FF10+ Chrome15+
                                                                  Windows 7 IE8+ FF10+ Chrome15+
                                                                  Windows 8 IE10 FF10+ Chrome15+
                                                                  Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                                • Cookie settings: session cookies enabled
                                                                • Browser configuration must have JavaScript enabled
                                                                • Adobe Flash player 10.2 or later

                                                                To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                                Internet Connection

                                                                • A minimum of 100Kbps is recommended for audio-only events
                                                                • A minimum of 300Kbps is recommended for speaker on-video events

                                                                Computer Equipment

                                                                • Screen Resolution: Minimum 1024x768
                                                                • Video Card: 65,000 colors minimum
                                                                • Sound card and speakers (or headphones) for hearing webcast in full format
                                                                • Audio Card: 16-bit minimum
                                                                • RAM: 512MB of free RAM

                                                                Firewall Protocol

                                                                • HTTP on port 80 or HTTPS on port 443
                                                                • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                                • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                                Work-At-Home Attendees

                                                                • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                                For A Seamless Experience

                                                                When using a mobile device, FREE Mobile Apps are available:

                                                                - For viewing Webinars:

                                                                - For viewing Virtual Events

                                                                Attendee Guide

                                                                • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                                Virtual Event and Webinar Support:

                                                                Continuing Education (CME/CE) Support

                                                                Loading Comments...
                                                                Show Resources
                                                                Event Countdown
                                                                • 0 Days
                                                                • 0 Hours
                                                                • 0 Minutes
                                                                • 0 Seconds